SCHEMBL4433753

SCHEMBL4433753

Fc1cccc2cc(CCNc3ncnc4[nH]cnc34)c(-c3ccc(C(F)(F)F)cc3)nc12

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 4/20 0.37
HTT P42858 3/20 0.37
LMNA P02545 3/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
PIK3CD O00329 3/20 0.34
TAAR1 Q96RJ0 1/20 0.32
SYK P43405 1/20 0.32
AURKA O14965 4/20 0.31
AURKB Q96GD4 3/20 0.31
RPS6KB1 P23443 1/20 0.31
MAPT P10636 1/20 0.31
GFER P55789 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
CLK4 Q9HAZ1 3/20 0.31
CYP1A2 P05177 2/20 0.31
CYP3A4 P08684 2/20 0.31
CYP2D6 P10635 2/20 0.31
CYP2C19 P33261 2/20 0.31
MEN1 O00255 1/20 0.31
USP2 O75604 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4434824 0.90 LMNA (0.42) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL16799113 0.87 LMNA (0.39) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL4433351 0.86 MAP4K4 (0.41) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL4435698 0.83 HTT (0.37) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL4434206 0.82 HTT (0.38) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL4443357 0.81 PIK3CD (0.40) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL4431745 0.81 HTT (0.38) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL4185136 0.80 PIK3CD (0.49) MAPK1HTTLMNAPIK3CDAURKA
SCHEMBL4433726 0.80 HTT (0.37) MAPK1HTTLMNASMN1; SMN2PIK3CD
SCHEMBL4179093 0.79 PIK3CG (0.44) PIK3CDAURKARPS6KB1DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137186-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES Amgen Inc. (US) 2009-12-30 EP disclosed
WO-2008118468-A1 HETEROCYCLIC COMPOUNDS AND THEIR USES AMGEN INC. (US) 2008-10-02 WO disclosed